Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | VSV-GP128 |
Trade Name | |
Synonyms | VSVGP128|VSV GP128|VSVGP 128|VSVGP-128 |
Drug Descriptions |
VSV-GP128 is a chimeric vesicular stomatitis virus (VSV) viral vector-based cancer vaccine containing tumor-associated antigen peptides, which potentially results in immune modulation and tumor cell killing (NCI Thesaurus). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C183521 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATP128 + Ezabenlimab + VSV-GP128 | ATP128 Ezabenlimab VSV-GP128 | 0 | 1 |
VSV-GP128 | VSV-GP128 | 0 | 0 |